The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells

The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells Prostate Cancer and Prostatic Diseases advance online publication, June 21 2016. doi:10.1038/pcan.2016.19 Authors: C Morell, A Bort, D Vara, A Ramos-Torres, N Rodríguez-Henche & I Díaz-Laviada

http://feeds.nature.com/~r/pcan/rss/aop/~3/PmQD9NPdWfA/pcan.2016.19

Source: Prostate Cancer and Prostatic Diseases - June 20, 2016 Category: Urology & Nephrology Authors: C MorellA BortD VaraA Ramos-TorresN Rodríguez-HencheI Díaz-Laviada Source Type: research

More News: Cancer | Cancer & Oncology | Neurology | Prostate Cancer | Urology & Nephrology